Annual Analysts Briefing – Presentation to the Hellenic Fund and Asset Management Association
Paiania, April 24, 2025 – Today, Lavipharm S.A. conducted its Annual Analyst Update in accordance with the Company’s Financial Calendar for 2025. The presentation took place at the Athens Stock Exchange and was organized by the Hellenic Fund and Asset Management Association.
In his opening remarks, Group CFO Vassilis Baloumis stated: “It is a profound honor and pleasure to be here for the third consecutive year, particularly as we reflect on the more than two years that have passed since our capital increase, which secured essential funding for the company’s growth. Our investments have started yielding positive results, significantly enhancing our profitability and enabling us, for the first time in 18 years, to reward our shareholders for their trust with a dividend of €0.02 per share.”
For the full press release, please read Lavipharm Annual Analysts Briefing.
You may access the presentation here.
